产品说明书

Sulbactam Acid

Print
Chemical Structure| 68373-14-8 同义名 : 舒巴坦 ;Sulbactam;CP45899;Penicillanic Acid Dioxide
CAS号 : 68373-14-8
货号 : A637045
分子式 : C8H11NO5S
纯度 : 98%
分子量 : 233.242
MDL号 : MFCD00867005
存储条件:

粉末 Sealed in dry,Store in freezer, under -20°C

液体 -20°C:3-6个月-80°C:12个月

溶解度 :

DMSO: 105 mg/mL(450.18 mM),注意:DMSO长时间开封后,会吸水并导致溶解能力下降,请避免使用长期开封的DMSO

H2O: 20 mg/mL(85.75 mM),配合低频超声助溶

动物实验配方:
生物活性
描述 Sulbactam is a competitive, irreversible beta-lactamase inhibitor. Its binding to penicillin-binding proteins imparts weak intrinsic antibacterial activity. Synergy of sulbactam with beta-lactam antibiotics is most marked in bacterial species in which beta lactamase is a major mechanism of resistance. Sulbactam sodium is available in combination with ampicillin sodium for injection in a 1:2 ratio of sulbactam to ampicillin. The minimal toxicity of sulbactam-ampicillin makes the combination appealing for the treatment of gram-negative nonpseudomonal and anaerobic infections[3]. The in-vitro activity of the sulbactam/ampicillin combination was by virtue of the antimicrobial activity exhibited by sulbactam. Sulbactam may prove effective for non-life-threatening A. baumannii infections[4]. Sulbactam combinations have not demonstrated strong selective pressures for extended-spectrum beta-lactamase-producing Enterobacteriaceae and vancomycin-resistant enterococci. In contrast to clavulanate, sulbactam does not induce class I (Ampc) chromosomal beta-lactamases in Enterobacteriaceae[5].
实验方案
1mg 5mg 10mg

1 mM

5 mM

10 mM

4.29mL

0.86mL

0.43mL

21.44mL

4.29mL

2.14mL

42.87mL

8.57mL

4.29mL

参考文献

[1]Corbella X, Ariza J, et al. Efficacy of sulbactam alone and in combination with ampicillin in nosocomial infections caused by multiresistant Acinetobacter baumannii. J Antimicrob Chemother. 1998 Dec;42(6):793-802.

[2]Urban C, Go E, et al. Effect of sulbactam on infections caused by imipenem-resistant Acinetobacter calcoaceticus biotype anitratus. J Infect Dis. 1993 Feb;167(2):448-51.

[3]Noguchi JK, Gill MA. Sulbactam: a beta-lactamase inhibitor. Clin Pharm. 1988;7(1):37–51

[4]Corbella X, Ariza J, Ardanuy C, et al. Efficacy of sulbactam alone and in combination with ampicillin in nosocomial infections caused by multiresistant Acinetobacter baumannii. J Antimicrob Chemother. 1998;42(6):793–802

[5]Akova M. Sulbactam-containing beta-lactamase inhibitor combinations [published correction appears in Clin Microbiol Infect. 2008 May;14 Suppl 5:21-4]. Clin Microbiol Infect. 2008;14 Suppl 1:185–188